Astria Therapeutics, Inc. (ATXS)
NASDAQ: ATXS · IEX Real-Time Price · USD
9.47
+0.46 (5.11%)
At close: May 31, 2024, 4:00 PM
9.88
+0.41 (4.33%)
After-hours: May 31, 2024, 6:25 PM EDT
Astria Therapeutics Market Cap
Astria Therapeutics has a market cap or net worth of $520.03 million as of May 31, 2024. Its market cap has increased by 47.27% in one year.
Market Cap
520.03M
Enterprise Value
150.29M
1-Year Change
47.27%
Ranking
Category
Stock Price
$9.47
Market Cap Chart
Since June 25, 2015, Astria Therapeutics's market cap has increased from $180.00M to $520.03M, an increase of 188.90%. That is a compound annual growth rate of 12.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 31, 2024 | 520.00M | 5.09% |
| May 30, 2024 | 494.80M | 0.45% |
| May 29, 2024 | 492.60M | -0.89% |
| May 28, 2024 | 497.00M | 0.34% |
| May 24, 2024 | 495.30M | - |
| May 23, 2024 | 495.30M | -1.00% |
| May 22, 2024 | 500.30M | -0.97% |
| May 21, 2024 | 505.20M | -4.06% |
| May 20, 2024 | 526.60M | 0.52% |
| May 17, 2024 | 523.90M | 1.18% |
| May 16, 2024 | 517.80M | 1.73% |
| May 15, 2024 | 509.00M | -2.32% |
| May 14, 2024 | 521.10M | -2.27% |
| May 13, 2024 | 533.20M | -0.21% |
| May 10, 2024 | 534.30M | -4.33% |
| May 9, 2024 | 558.50M | 6.30% |
| May 8, 2024 | 525.40M | -4.11% |
| May 7, 2024 | 547.90M | 2.14% |
| May 6, 2024 | 536.40M | 2.31% |
| May 3, 2024 | 524.30M | 2.14% |
| May 2, 2024 | 513.30M | -1.59% |
| May 1, 2024 | 521.60M | 3.49% |
| Apr 30, 2024 | 504.00M | 0.32% |
| Apr 29, 2024 | 502.40M | 1.68% |
| Apr 26, 2024 | 494.10M | -1.87% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Y-mAbs Therapeutics | 530.98M |
| PepGen | 529.37M |
| Cross Country Healthcare | 525.78M |
| Entrada Therapeutics | 522.25M |
| Allogene Therapeutics | 521.96M |
| Orthofix Medical | 515.28M |
| Avid Bioservices | 513.55M |
| GeneDx Holdings | 512.82M |